Christophe Tournigand
Inserm(FR)Université Paris-Est Créteil(FR)Centre Hospitalier Universitaire Henri-Mondor(FR)Assistance Publique – Hôpitaux de Paris(FR)GERCOR (France)(FR)Hôpitaux Universitaires Henri-Mondor(FR)Université Gustave Eiffel(FR)Hôpital Albert-Chenevier(FR)Institut Mondor de Recherche Biomédicale(FR)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Gastric Cancer Management and Outcomes, Genetic factors in colorectal cancer, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study(2003)2,904 cited
- → Potential of fecal microbiota for early‐stage detection of colorectal cancer(2014)1,407 cited
- → OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study(2006)800 cited
- → Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study(2015)665 cited
- → Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database(2016)632 cited
- →